Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,488 papers from all fields of science
Search
Sign In
Create Free Account
CDK4 gene
Known as:
CDK4
, Cyclin-Dependent Kinase 4 Gene
, CELL DIVISION KINASE 4
Expand
This gene is involved in G1 stage cell cycle progression.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
CDK4 protein, human
Cell Cycle Control
Cell Proliferation
Cyclin-Dependent Kinase 4
Expand
Narrower (1)
CDK4 wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
MicroRNA-338-3p Inhibits Proliferation and Promotes Apoptosis of Multiple Myeloma Cells Through Targeting Cyclin-Dependent Kinase 4.
Yang Cao
,
Xu Shi
,
Yingmin Liu
,
R. Xu
,
Q. Ai
Oncology Research
2018
Corpus ID: 29470517
MicroRNA-338-3p (miR-338-3p) has been reported to be a tumor suppressor in multiple cancer types. However, the biological role of…
Expand
2017
2017
A3 adenosine receptor agonist induce G1 cell cycle arrest via Cyclin D and cyclin-dependent kinase 4 pathways in OVCAR-3 and Caov-4 cell lines
H. Joshaghani
,
S. Jafari
,
M. Aghaei
,
M. Panjehpour
,
Hamideh Abedi
Journal of Cancer Research and Therapeutics
2017
Corpus ID: 3390196
Aim of the Study: The cell cycle, a vital process that involves in cells' growth and division, lies at the heart of cancer. It…
Expand
2017
2017
Arctigenin, a natural lignan compound, induces G0/G1 cell cycle arrest and apoptosis in human glioma cells.
Aisha Maimaitili
,
Zunhua Shu
,
Xiaojiang Cheng
,
Kadeer Kaheerman
,
Alifu Sikandeer
,
Weimin Li
Oncology Letters
2017
Corpus ID: 31770490
The aim of the current study was to investigate the anticancer potential of arctigenin, a natural lignan compound, in malignant…
Expand
2017
2017
Pien Tze Huang inhibits the growth of hepatocellular carcinoma cells by upregulating miR-16 expression.
F. Qi
,
Songqiang Zhou
,
+5 authors
Jun Peng
Oncology Letters
2017
Corpus ID: 4649686
Hepatocellular carcinoma (HCC) is characterized by uncontrolled proliferation and the deregulation of apoptotic signaling…
Expand
2005
2005
A Mimic of p21WAF1/CIP1 Ameliorates Murine Lupus1
C. Goulvestre
,
C. Chéreau
,
C. Nicco
,
L. Mouthon
,
B. Weill
,
F. Batteux
Journal of Immunology
2005
Corpus ID: 23133917
Systemic lupus erythematosus (SLE) is a progressive autoimmune disease characterized by the production of high levels of affinity…
Expand
2004
2004
Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma
R. Kappler
,
Regine Bauer
,
J. Calzada-Wack
,
M. Rosemann
,
B. Hemmerlein
,
H. Hahn
Oncogene
2004
Corpus ID: 21615463
Rhabdomyosarcoma (RMS) is a highly malignant tumor that is histologically related to skeletal muscle, yet genetic and molecular…
Expand
1999
1999
Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture.
N. Kawada
,
K. Ikeda
,
S. Seki
,
T. Kuroki
Journal of Hepatology
1999
Corpus ID: 39798539
1997
1997
Infrequent mutations of p16INK4A and p15INK4B genes in human pituitary adenomas.
K. Yoshimoto
,
C. Tanaka
,
+4 authors
M. Itakura
European Journal of Endocrinology
1997
Corpus ID: 44743302
The p16INK4A and p15INK4B genes on chromosome 9p21 encode the p16 and p15 inhibitors of cyclin D/cyclin-dependent kinase 4…
Expand
1995
1995
Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma.
PR Koduru
,
M. Zariwala
,
M. Soni
,
JZ Gong
,
Y. Xiong
,
J. Broome
Blood
1995
Corpus ID: 13523773
B-cell non-Hodgkin's lymphoma (NHL) is a heterogeneous lymphoid malignancy consisting of several histologic types. Alterations in…
Expand
1995
1995
Low frequency of CDKN2 mutation in endometrial carcinomas
Stacia L. Peiffer
,
D. Bartsch
,
A. Whelan
,
D. Mutch
,
T. Herzog
,
P. Goodfellow
Molecular Carcinogenesis
1995
Corpus ID: 43158742
The CDKN2 gene on chromosome 9p21 encodes the p16 inhibitor of cyclin D/cyclin‐dependent kinase 4 complexes. Mutations and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE